SCHEMBL30705253

SCHEMBL30705253

Cn1cc(-c2ncnc(Nc3cc([N+](=O)[O-])c(F)cc3OC(F)F)n2)c2cc(F)ccc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 11/20 0.37
CDK9 P50750 8/20 0.36
CCNT1 O60563 7/20 0.36
CCNE1 P24864 7/20 0.36
CDK2 P24941 7/20 0.36
CCNE2 O96020 2/20 0.34
GSK3A P49840 2/20 0.34
GSK3B P49841 2/20 0.34
CDK5 Q00535 2/20 0.34
AURKA O14965 1/20 0.34
JAK2 O60674 1/20 0.34
PAK4 O96013 1/20 0.34
ABL1 P00519 1/20 0.34
NTRK1 P04629 1/20 0.34
LCK P06239 1/20 0.34
FYN P06241 1/20 0.34
CSF1R P07333 1/20 0.34
RET P07949 1/20 0.34
IGF1R P08069 1/20 0.34
MET P08581 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24240378 1.00 EGFR (0.37) EGFRCDK9CCNT1CCNE1CDK2
SCHEMBL29162975 0.94 EGFR (0.38) EGFRCDK9CCNT1CCNE1CDK2
SCHEMBL24240390 0.91 EGFR (0.44) EGFRCDK9CCNT1CCNE1CDK2
SCHEMBL24496892 0.87 EGFR (0.39) EGFRCDK9CCNT1CCNE1CDK2
SCHEMBL24240388 0.87 EGFR (0.50) EGFR
SCHEMBL18606916 0.86 FGFR3 (0.35) EGFRCDK9CCNT1CCNE1CDK2
SCHEMBL30705259 0.84 MKNK1 (0.45) EGFRCDK9CCNT1CCNE1CDK2
SCHEMBL24240383 0.84 MKNK1 (0.45) EGFRCDK9CCNT1CCNE1CDK2
SCHEMBL24240376 0.84 EGFR (0.38) EGFRCDK9CCNT1CCNE1CDK2
SCHEMBL30460067 0.80 EGFR (0.54) EGFRJAK2FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111747950-B Pyrimidine derivatives for the treatment of cancer 深圳福沃药业有限公司 2024-01-23 CN disclosed